Application 065422
- Type
- ANDA
- Sponsor
- VISTAPHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NYSTATIN | NYSTATIN | SUSPENSION;ORAL | 100,000 UNITS/ML | No | No |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-08 23:34 UTC | 2022-04 | A065422-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2011-03-07 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A065422-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2011-03-07 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A065422-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2011-03-07 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A065422-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2011-03-07 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A065422-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2011-03-07 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A065422-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2011-03-07 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A065422-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2011-03-07 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A065422-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2011-03-07 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A065422-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2011-03-07 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A065422-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2011-03-07 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A065422-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2011-03-07 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A065422-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2011-03-07 | ea99ee380514… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-04-08 23:34 UTC | 2022-04 | A065422-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A065422-001 | AA | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A065422-001 | AA | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A065422-001 | AA | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A065422-001 | AA | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A065422-001 | AA | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A065422-001 | AA | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A065422-001 | AA | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A065422-001 | AA | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A065422-001 | AA | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A065422-001 | AA | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A065422-001 | AA | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystatin | NYSTATIN | Bryant Ranch Prepack | 93d59122-86f3-489d-9790-1ef6c6aff89d | 2024-03-26 | Adverse reactions | Nystatin NYSTATIN |
| Nystop | NYSTATIN | Bryant Ranch Prepack | 87175864-9877-4e80-b870-907abb8ac289 | 2024-03-22 | Adverse reactions | NYSTATIN |
| Nystatin | NYSTATIN | Padagis Israel Pharmaceuticals Ltd | e630aa3d-11a6-4300-942a-cbdf2d016f77 | 2024-03-01 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | American Health Packaging | d8c251a6-d4da-4664-bff4-6868541d1178 | 2024-02-22 | Adverse reactions | Nystatin NYSTATIN |
| Nystop | NYSTATIN | Bryant Ranch Prepack | 5bce98a3-2964-4edc-b8da-8a46dafadf5e | 2024-01-11 | Adverse reactions | NYSTATIN |
| Nystatin | NYSTATIN | Proficient Rx LP | 8566c432-741f-4af7-91d7-1b7668ce5e95 | 2023-12-01 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN OINTMENT | Cosette Pharmaceuticals, Inc. | 8f87de59-33f2-32af-ae17-78bf30fb424d | 2023-11-29 | Adverse reactions | Nystatin |
| Nystatin | NYSTATIN | A-S Medication Solutions | 6a3bb3da-adf9-46d2-a5ff-f796e7aae7a1 | 2023-11-24 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | Zydus Pharmaceuticals USA Inc. | 2daf159d-6a12-4b5d-97b3-8069c17e7635 | 2023-11-04 | Adverse reactions | NYSTATIN NYSTATIN |
| Nystatin | NYSTATIN | Actavis Pharma, Inc. | aee7ce4c-8cc6-4446-a4d7-63bc4773066f | 2023-10-30 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | A-S Medication Solutions | cc3516cd-985c-489f-b4a1-8477876c5a97 | 2023-10-19 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | 53d1c23b-9cf2-4941-8701-8a7da1b066cc | 2023-03-03 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | 84383bc5-1282-43d6-9303-23c8fd8d075f | 2023-03-03 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | A-S Medication Solutions | e069d495-7f1a-4970-8f4d-aa93d124b3fc | 2023-02-04 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | Bryant Ranch Prepack | b06c65cd-5b65-4bc6-aae9-b9381c6f1948 | 2023-01-26 | Adverse reactions | NYSTATIN NYSTATIN |
| Nystatin | NYSTATIN CREAM | Cosette Pharmaceuticals, Inc. | ec1b52af-d38e-eba1-e63c-dba4341d3af2 | 2022-11-22 | Adverse reactions | Nystatin |
| Nystatin | NYSTATIN CREAM | Proficient Rx LP | b1efcc2c-f71a-463d-9a02-fad7550f31ec | 2022-11-01 | Adverse reactions | Nystatin |
| Nystatin | NYSTATIN | Teva Pharmaceuticals USA, Inc. | f03b294d-10cd-4bba-92c8-42ae9b110cd0 | 2022-11-01 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Viona Pharmaceuticals Inc | e135a7d2-adba-48a2-b3e1-07b778cce9b0 | 2022-10-08 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Proficient Rx LP | d7d04c02-d07d-4382-8f93-5c0c3e68790c | 2022-10-01 | Adverse reactions | Nystatin NYSTATIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 63629-8519 | Nystatin | Nystatin | Bryant Ranch Prepack | ANDA | Current |
| 63629-8519 | Nystatin | Nystatin | Bryant Ranch Prepack | ANDA | Current |
| 63629-8521 | Nystatin | Nystatin | Bryant Ranch Prepack | ANDA | Current |
| 63629-8521 | Nystatin | Nystatin | Bryant Ranch Prepack | ANDA | Current |
| 64950-230 | Nystatin | Nystatin | Genus Lifescience Inc. | ANDA | Current |
| 66689-008 | Nystatin | Nystatin | VistaPharm, Inc. | ANDA | Current |
| 66689-008 | Nystatin | Nystatin | VistaPharm, Inc. | ANDA | Current |
| 66689-008 | Nystatin | Nystatin | VistaPharm, Inc. | ANDA | Current |
| 66689-008 | Nystatin | Nystatin | VistaPharm, Inc. | ANDA | Current |